David Chernoff, MD
Family Medicine · Staunton, VANPI 1295705614
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Sunovion Pharmaceuticals Inc.. That places this record below the midpoint for family medicine clinicians in VA, where the typical reported total is $253.
Across 2 payments — averaging $6.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$14
What the payments were for
- Food & beverage$14100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 2 | $14 |
How this compares
$14 in reported general payments places this provider in the 0th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 238 | $241,343 |
| JardianceEmpagliflozin | 146 | $152,698 |
| OzempicSemaglutide | 83 | $117,975 |
| TrulicityDulaglutide | 70 | $93,382 |
| XareltoRivaroxaban | 62 | $77,671 |
| MyrbetriqMirabegron | 78 | $71,067 |
| FarxigaDapagliflozin Propanediol | 53 | $60,285 |
| JanuviaSitagliptin Phosphate | 49 | $52,747 |
| LinzessLinaclotide | 39 | $37,360 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $30,988 |
| RybelsusSemaglutide | 19 | $27,948 |
| MounjaroTirzepatide | 19 | $19,787 |
| Advair HfaFluticasone Propion/Salmeterol | 35 | $16,841 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 31 | $14,441 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $14,173 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Staunton
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.